193 related articles for article (PubMed ID: 15893468)
1. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1.
Spudich A; Frigg R; Kilic E; Kilic U; Oesch B; Raeber A; Bassetti CL; Hermann DM
Neurobiol Dis; 2005 Nov; 20(2):442-9. PubMed ID: 15893468
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia.
Weise J; Doeppner TR; Müller T; Wrede A; Schulz-Schaeffer W; Zerr I; Witte OW; Bähr M
Restor Neurol Neurosci; 2008; 26(1):57-64. PubMed ID: 18431006
[TBL] [Abstract][Full Text] [Related]
3. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury.
Weise J; Sandau R; Schwarting S; Crome O; Wrede A; Schulz-Schaeffer W; Zerr I; Bähr M
Stroke; 2006 May; 37(5):1296-300. PubMed ID: 16574930
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of PAR-2 gene increases acute focal ischemic brain injury.
Jin G; Hayashi T; Kawagoe J; Takizawa T; Nagata T; Nagano I; Syoji M; Abe K
J Cereb Blood Flow Metab; 2005 Mar; 25(3):302-13. PubMed ID: 15647743
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 deficiency increases cerebral ischemic injury.
Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
[TBL] [Abstract][Full Text] [Related]
6. Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia.
Chen H; Luo J; Kintner DB; Shull GE; Sun D
J Cereb Blood Flow Metab; 2005 Jan; 25(1):54-66. PubMed ID: 15678112
[TBL] [Abstract][Full Text] [Related]
7. MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia.
West DA; Valentim LM; Lythgoe MF; Stephanou A; Proctor E; van der Weerd L; Ordidge RJ; Latchman DS; Gadian DG
Neuroscience; 2004; 127(2):333-9. PubMed ID: 15262323
[TBL] [Abstract][Full Text] [Related]
8. Repression of phospho-JNK and infarct volume in ischemic brain of JIP1-deficient mice.
Im JY; Lee KW; Kim MH; Lee SH; Ha HY; Cho IH; Kim D; Yu MS; Kim JB; Lee JK; Kim YJ; Youn BW; Yang SD; Shin HS; Han PL
J Neurosci Res; 2003 Oct; 74(2):326-32. PubMed ID: 14515362
[TBL] [Abstract][Full Text] [Related]
9. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice.
Kilic U; Kilic E; Reiter RJ; Bassetti CL; Hermann DM
J Pineal Res; 2005 Jan; 38(1):67-71. PubMed ID: 15617539
[TBL] [Abstract][Full Text] [Related]
11. The role of the octarepeat region in neuroprotective function of the cellular prion protein.
Mitteregger G; Vosko M; Krebs B; Xiang W; Kohlmannsperger V; Nölting S; Hamann GF; Kretzschmar HA
Brain Pathol; 2007 Apr; 17(2):174-83. PubMed ID: 17388948
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity.
Weise J; Crome O; Sandau R; Schulz-Schaeffer W; Bähr M; Zerr I
Neurosci Lett; 2004 Nov; 372(1-2):146-50. PubMed ID: 15531106
[TBL] [Abstract][Full Text] [Related]
13. Sustained astrocytic clusterin expression improves remodeling after brain ischemia.
Imhof A; Charnay Y; Vallet PG; Aronow B; Kovari E; French LE; Bouras C; Giannakopoulos P
Neurobiol Dis; 2006 May; 22(2):274-83. PubMed ID: 16473512
[TBL] [Abstract][Full Text] [Related]
14. Effects of transient focal cerebral ischemia in mice deficient in puma.
Kuroki K; Virard I; Concannon CG; Engel T; Woods I; Taki W; Plesnila N; Henshall DC; Prehn JH
Neurosci Lett; 2009 Feb; 451(3):237-40. PubMed ID: 19159665
[TBL] [Abstract][Full Text] [Related]
15. Differential early mitogen-activated protein kinase activation in hyperglycemic ischemic brain injury in the rat.
Farrokhnia N; Roos MW; Terént A; Lennmyr F
Eur J Clin Invest; 2005 Jul; 35(7):457-63. PubMed ID: 16008548
[TBL] [Abstract][Full Text] [Related]
16. Poxvirus-derived cytokine response modifier A (CrmA) does not protect against focal cerebral ischemia in mice.
Kilic E; Wippel A; Kilic U; Vogel P; Kim M; van der Putten H; Wiessner C; Rovelli G; Böttiger BW; Hermann DM
Brain Res; 2007 Dec; 1185():293-300. PubMed ID: 18028883
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse.
Oprica M; Van Dam AM; Lundkvist J; Iverfeldt K; Winblad B; Bartfai T; Schultzberg M
Acta Neuropathol; 2004 Jul; 108(1):69-80. PubMed ID: 15138779
[TBL] [Abstract][Full Text] [Related]
19. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.
Kiprianova I; Schindowski K; von Bohlen und Halbach O; Krause S; Dono R; Schwaninger M; Unsicker K
Exp Neurol; 2004 Oct; 189(2):252-60. PubMed ID: 15380477
[TBL] [Abstract][Full Text] [Related]
20. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
Beamer CA; Brooks DM; Lurie DI
J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
